Home LiteratureArticle Details
PMID: 12493175 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.

Diagnostic microbiology and infectious disease ·Vol. 44 ·No. 3 ·2002-11-00 ·Pages 273-80

Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ, SENTRY Participants Group Latin America

Abstract

As part of the Latin American arm of the SENTRY Antimicrobial Surveillance Program, 7,207 bacterial isolates collected consecutively from bloodstream infections (BSI) during the period of January 1997 through December 2000 were analyzed. Ten Latin American laboratories located in six countries participated in the study during each year. Antimicrobial susceptibility testing was performed using the reference NCCLS broth microdilution method. The most frequently isolated species were (n/%): Staphylococcus aureus (1,532/21.3%), Escherichia coli (1,239/17.2%), coagulase-negative Staphylococcus (1,002/13.9%), Klebsiella pneumoniae (664/9.2%), and Pseudomonas aeruginosa (470/6.5%). The prevalence of S. aureus as a cause of BSI increased from 20.5% in 1997 to 23.3% in 2000 (p = 0.011), but oxacillin-resistance rates remained relatively stable during this period (around 30%). Enterococci (216 isolates) showed low rates of resistance to both vancomycin (2.4%) and ampicillin (7.9%) and 72.7% of 289 Streptococcus pneumoniae isolates evaluated were susceptible to penicillin (MIC </=0.06 microg/mL). Resistance rates among Gram-negative bacilli were much higher than those reported in other regions evaluated in the SENTRY Program. The main antimicrobial resistance problems among these pathogens were the high prevalences of ESBL-producing E. coli (6.7%) and K. pneumoniae (47.3%), and carbapenem-resistance among P. aeruginosa (around 12%) and Acinetobacter spp. (around 10%). P. aeruginosa resistance rates to meropenem, piperacillin/tazobactam, amikacin, and ciprofloxacin showed a significant increase during the 4-year period evaluated. Resistance rates varied according to the country for several pathogen-antimicrobial combinations. In summary, resistance to most antimicrobial agents for a number of species implicated in bacteremia, especially among Gram-negative rods, has reached worrisome levels and continues to increase.

MeSH Terms
Anti-Bacterial Agents/pharmacology Bacteremia/epidemiology,microbiology Bacterial Infections/epidemiology,microbiology Drug Resistance, Bacterial Gram-Negative Bacteria/drug effects,isolation & purification Gram-Positive Bacteria/drug effects,isolation & purification Hospitals Humans Latin America/epidemiology Microbial Sensitivity Tests/methods Prevalence Sentinel Surveillance
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sader Helio S
Laboratório Especial de Microbiologia Clínica, Division of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, Brazil. heliosader@uol.com.br
Jones Ronald N
Andrade-Baiocchi Soraya
Biedenbach Douglas J
SENTRY Participants Group (Latin America)
Article Info
Journal
Diagnostic microbiology and infectious disease
Abbr.
Diagn Microbiol Infect Dis
ISSN
0732-8893
Published
2002-11-00
Pages
273-80
Language
English
Region
United States
NLM ID
8305899
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com